135 related articles for article (PubMed ID: 3466644)
21. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia.
Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P
J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987
[TBL] [Abstract][Full Text] [Related]
22. A modern classification of the acute non-lymphoblastic leukaemias.
Hayhoe FG
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():70-2. PubMed ID: 2653522
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia.
Merle-Beral H; Nguyen Cong Duc L; Leblond V; Boucheix C; Michel A; Chastang C; Debre P
Br J Haematol; 1989 Nov; 73(3):323-30. PubMed ID: 2605121
[TBL] [Abstract][Full Text] [Related]
24. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
25. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
[TBL] [Abstract][Full Text] [Related]
26. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
[TBL] [Abstract][Full Text] [Related]
27. Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia.
Roberts GT; Spence DG; Padmos MA; Sheth KV; Clink H; Ernst P
Leuk Res; 1992; 16(2):181-90. PubMed ID: 1545571
[TBL] [Abstract][Full Text] [Related]
28. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.
Raife TJ; Lager DJ; Kemp JD; Dick FR
Am J Clin Pathol; 1994 Mar; 101(3):296-9. PubMed ID: 7510927
[TBL] [Abstract][Full Text] [Related]
29. Unexpected absence of a myeloid surface antigen (3-fucosyl-N-acetyllactosamine) in promyelocytic leukemia.
Bettelheim P; Panzer S; Majdic O; Stockinger H; Roithner A; Köller U; Meryn S; Lechner K; Knapp W
Leuk Res; 1985; 9(11):1323-7. PubMed ID: 3866114
[TBL] [Abstract][Full Text] [Related]
30. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
Drexler HG; Sagawa K; Menon M; Minowada J
Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
[TBL] [Abstract][Full Text] [Related]
31. A comparison of surface marker analysis and FAB classification in acute myeloid leukemia.
van der Reijden HJ; van Rhenen DJ; Lansdorp PM; van't Veer MB; Langenhuijsen MM; Engelfriet CP; von dem Borne AE
Blood; 1983 Mar; 61(3):443-8. PubMed ID: 6572076
[TBL] [Abstract][Full Text] [Related]
32. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
[TBL] [Abstract][Full Text] [Related]
33. Surface marker expression in acute myeloid leukaemia at first relapse.
Thomas X; Campos L; Archimbaud E; Shi ZH; Treille-Ritouet D; Anglaret B; Fiere D
Br J Haematol; 1992 May; 81(1):40-4. PubMed ID: 1381608
[TBL] [Abstract][Full Text] [Related]
34. CD34+/CD33+ blast cells: correlation with FAB subtypes.
Rigolin GM; Lanza F; Ferrari L; Castoldi G
Leuk Lymphoma; 1995; 18 Suppl 1():43-8. PubMed ID: 7496354
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotype of blast cells in acute myeloid leukemia may be a useful predictive factor for outcome.
Tucker J; Dorey E; Gregory WM; Simpson AP; Amess JA; Lister TA; Horton MA
Hematol Oncol; 1990; 8(1):47-58. PubMed ID: 2404842
[TBL] [Abstract][Full Text] [Related]
36. Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia.
Bettelheim P; Lutz D; Majdic O; Paietta E; Haas O; Linkesch W; Neumann E; Lechner K; Knapp W
Br J Haematol; 1985 Mar; 59(3):395-409. PubMed ID: 3855651
[TBL] [Abstract][Full Text] [Related]
37. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.
Master PS; Richards SJ; Kendall J; Roberts BE; Scott CS
Blut; 1989 Sep; 59(3):221-5. PubMed ID: 2477088
[TBL] [Abstract][Full Text] [Related]
39. Definition of AML susceptibility and classification using monoclonal antibodies.
Seremetis S; Cuttner J; Winchester R
Med Oncol Tumor Pharmacother; 1984; 1(4):263-7. PubMed ID: 6599464
[TBL] [Abstract][Full Text] [Related]
40. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
Billing RJ; Foon KA; Linker-Israeli M
Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
